DTIL
DTIL
NASDAQ · Biotechnology

Precision Biosciences Inc

$3.80
+0.23 (+6.44%)
As of Feb 8, 2:12 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 15.36M 15.69M 16.28M
Net Income 427.8K 557.5K 468.9K
EPS
Profit Margin 2.8% 3.6% 2.9%
Rev Growth -9.8% -7.6% +22.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 22.45M 24.76M 28.30M
Total Equity 67.64M 61.10M 66.63M
D/E Ratio 0.33 0.41 0.42
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 737.1K 726.6K 787.3K
Free Cash Flow 462.7K 441.5K 603.2K